Related Experiment Video

Updated: Oct 19, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.2K

Circ_0128846/miR-140-3p/JAK2 Network in Osteoarthritis Development

Hongjun Li1, Zhongyu Liu2, Xiaoyun Guo1,3

  • 1Department of Rheumatology and Immunology, The Second Hospital of Tianjin Medical University, Tianjin, China.

Immunological Investigations
|September 21, 2021
PubMed

Insights

Circular RNA circ_0128846 promotes osteoarthritis (OA) by sponging miR-140-3p and upregulating JAK2. Silencing circ_0128846 alleviates OA progression, suggesting it as a therapeutic target for osteoarthritis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are key regulators of gene expression, influencing microRNA (miRNA) function, transcription, and splicing.
  • Osteoarthritis (OA) is a degenerative joint disease with complex molecular underpinnings, necessitating the identification of novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of the novel circRNA, circ_0128846, in the progression of osteoarthritis (OA).
  • To elucidate the molecular mechanism by which circ_0128846 influences OA pathogenesis, focusing on its interaction with miR-140-3p and JAK2.

Main Methods:

  • Isolation of tissues and chondrocytes from OA patients and construction of experimental OA rat models.
  • Overexpression and knockdown of circ_0128846 and JAK2 using cell transfection and siRNA interference.
  • Quantitative real-time PCR (qRT-PCR), Western blot, dual-luciferase reporter assays, RNA immunoprecipitation (RIP), and immunohistochemistry (IHC) to assess gene expression and interactions.
  • Hematoxylin and eosin (H&E) and Safranin O staining for pathological evaluation in animal models.

Main Results:

  • Circ_0128846 and JAK2 were upregulated, while miR-140-3p was downregulated in OA patients.
  • Circ_0128846 silencing enhanced chondrocyte viability, reduced apoptosis and inflammation, and suppressed MMP-13 while promoting collagen II expression by modulating the miR-140-3p/JAK2 axis.
  • In vivo studies confirmed that circ_0128846 silencing attenuated OA progression and promoted collagen II expression.

Conclusions:

  • Circ_0128846 acts as a sponge for miR-140-3p, increasing JAK2 expression and contributing to OA development.
  • Targeting circ_0128846 demonstrates potential for alleviating OA progression, highlighting its significance as a therapeutic target.
Keywords:
Circular RNAscompetitive endogenous RNAmicroRNAosteoarthritis

More Related Videos

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.2K
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

4.0K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
6.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K